|
Showing 1 - 2 of
2 matches in All Departments
Chronic viral hepatitis remains one of the major medical problems
worldwide. Neither a cure nor eradication of this disease is in
sight. The chronic disease caused by hepatitis viruses type B, C
and D is a much greater problem than the acute disease caused by
the same viruses or by hepatitis viruses type A and E. Chronic
viral hepatitis often remains unrecognized until the patient
develops decompensated liver cirrhosis or hepatocellular carcinoma.
Furthermore, unrecognized chronic virus carriers are a persistent
source of infection by sexual and other close contacts as well as
during many medical procedures. The viruses of chronic hepatitis
are very different from each other from a taxonomical point of
view, but they share many common pathogenic properties and they
often coinfect individuals. Six years ago Carlo De Bac, Gloria
Taliani (Rome) and I undertook an effort to bring together, under
the auspices of the European Society against Virus Diseases,
clinicians, laboratory physicians, epidemiologists, pathologists
and molecular biologists whose primary research interest is chronic
viral hepatitis. The contributions from these quite divergent
participants to a meeting devoted solely to chronic viral hepatitis
were most stimulating and valuable. As a result of the success of
the first meeting in Fiuggi (Italy), a second followed in Siena
(Italy) 1990 and the recent third meeting was held in Pisa (Italy).
Most of the speakers expressed interest in publishing their
contributions in the form of a proceedings volume, as was done in
the case of the Siena meeting.
Chronic viral hepatitis is discussed here in a multidisciplinary
approach. The editors' goal was to assemble contributions from
clinicians, laboratory physicians, epidemiologists, pathologists,
and molecular biologists to provide a synopsis of all the important
aspects of this disease. A key element in the chronic evolution of
viral hepatitis is the persistent coexistence of a cytotoxic immune
response and viral gene expression which is discussed in eleven
articles on immune pathogenesis. The oncogenicity of hepatitis B
virus at the molecular level and of hepatitis C virus at the
epidemiological level is discussed in two chapters. The application
of PCR for the detection of hepatitis viruses and their variants is
a major topic of both practical and theoretical interest. The
clinical significance of newly developed serological assays for
diagnosis and prevention is discussed in depth by specialists from
clinics, transfusion centers and virological laboratories. The
therapy of chronic viral hepatitis is still unsatisfactory, but
some slow progress is described in several articles. Furthermore,
the volume has a special chapter on the often neglected topic of
chronic hepatitis in childhood.
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.